Health Catalyst, Inc. (HCAT)

NASDAQ:
HCAT
| Latest update: Mar 1, 2026, 7:03 PM

Stock events for Health Catalyst, Inc. (HCAT)

Daniel Burton announced he would step down as CEO in August 2025, with retirement planned for June 30, 2026. Health Catalyst released its Q3 2025 earnings in November 2025, reporting an EPS of $0.06 and quarterly revenue of $76.32 million, both exceeding expectations. Several insider stock transactions occurred in December 2025, primarily sales by executives and directors. In January 2026, the company pre-released its Q4 2025 results, with revenue slightly above consensus and EBITDA in line with expectations. Stifel reiterated a "Buy" rating for HCAT in January 2026, with a $3.75 price target, despite mixed forward guidance. A buy signal was issued in February 2026, and the stock rose 2.87%. The stock has experienced volatility and holds sell signals from both short and long-term Moving Averages. The stock price has decreased by 95.86% over the past 5 years.

Demand Seasonality affecting Health Catalyst, Inc.’s stock price

The first quarter (Q1) is typically a softer quarter for bookings for Health Catalyst. Despite this seasonality, Health Catalyst added 10 net new platform clients in Q1 2025, indicating a positive underlying demand situation.

Overview of Health Catalyst, Inc.’s business

Health Catalyst, Inc. operates in the Healthcare sector, providing data and analytics technology and services to healthcare organizations. Its products and services include the cloud-based Health Catalyst Ignite ecosystem, analytics applications, professional services, patient engagement solutions like Twistle Patient Engagement and Lumeon Care Orchestration, and AI-powered tools. Recent developments include the acquisition of Lumeon Limited in August 2024 and a definitive agreement to acquire Intraprise Health in November 2024. In April 2025, Health Catalyst launched Health Catalyst Ignite Spark™ for community health systems.

HCAT’s Geographic footprint

Health Catalyst is headquartered in South Jordan, Utah, and primarily serves healthcare organizations across the United States. The company has expanding capabilities in the United Kingdom and North America, with additional office locations in Salt Lake City, Boston, Minneapolis, Columbus, and Pittsburgh.

HCAT Corporate Image Assessment

Health Catalyst has maintained a positive brand reputation, receiving recognition from Newsweek as a top healthcare data analytics and digital health company. Modern Healthcare has recognized Health Catalyst for 12 consecutive years as a Best Place to Work in healthcare. The launch of Health Catalyst Ignite Spark™ in April 2025 also contributes positively to its brand.

Ownership

Health Catalyst has significant institutional ownership, with major holders including First Light Asset Management, LLC, BlackRock, Inc., and Vanguard Group Inc. The largest individual shareholder is Mathew Paul Arens, owning 11.03 million shares, representing 15.59% of the company.

Expert AI

Show me the sentiment for Health Catalyst, Inc.
What's the latest sentiment for Health Catalyst, Inc.?

Price Chart

$1.62

7.43%
(1 month)

Top Shareholders

First Light Asset Management LLC
18.25%
BlackRock, Inc.
7.34%
The Vanguard Group, Inc.
6.27%
CDC Financial, Inc
5.66%
Whetstone Capital Advisors LLC
5.30%
Impax Asset Management Group Plc
3.89%
Nepsis, Inc.
2.71%
Geode Holdings Trust
2.36%

Trade Ideas for HCAT

Today

Sentiment for HCAT

News
Social

Buzz Talk for HCAT

Today

Social Media

FAQ

What is the current stock price of Health Catalyst, Inc.?

As of the latest update, Health Catalyst, Inc.'s stock is trading at $1.62 per share.

What’s happening with Health Catalyst, Inc. stock today?

Today, Health Catalyst, Inc. stock is down by -7.43%, possibly due to news.

What is the market sentiment around Health Catalyst, Inc. stock?

Current sentiment around Health Catalyst, Inc. stock is negative, based on recent news, trading volume, and analyst opinions.

Is Health Catalyst, Inc.'s stock price growing?

Over the past month, Health Catalyst, Inc.'s stock price has decreased by -7.43%.

How can I buy Health Catalyst, Inc. stock?

You can buy Health Catalyst, Inc. stock through any brokerage platform, such as e.g., Robinhood, Fidelity, E*TRADE, by searching for the ticker symbol HCAT

Who are the major shareholders of Health Catalyst, Inc. stock?

Major shareholders of Health Catalyst, Inc. include institutions such as First Light Asset Management LLC (18.25%), BlackRock, Inc. (7.34%), The Vanguard Group, Inc. (6.27%) ... , according to the latest filings.